These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11325032)

  • 1. Insulin self-association and the relationship to pharmacokinetics and pharmacodynamics.
    DeFelippis MR; Chance RE; Frank BH
    Crit Rev Ther Drug Carrier Syst; 2001; 18(2):201-64. PubMed ID: 11325032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical strategies for controlling peaks and valleys: type 1 diabetes.
    Bolli GB
    Int J Clin Pract Suppl; 2002 Jul; (129):65-74. PubMed ID: 12166610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational use of insulin analogues in the treatment of type 1 diabetes mellitus.
    Bolli GB
    Pediatr Endocrinol Rev; 2003 Sep; 1(1):9-21. PubMed ID: 16437009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled insulin: Exubera.
    Odegard PS; Capoccia KL
    Ann Pharmacother; 2005 May; 39(5):843-53. PubMed ID: 15827072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity.
    Kohn WD; Micanovic R; Myers SL; Vick AM; Kahl SD; Zhang L; Strifler BA; Li S; Shang J; Beals JM; Mayer JP; DiMarchi RD
    Peptides; 2007 Apr; 28(4):935-48. PubMed ID: 17328992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia.
    Bolli GB
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):13-20. PubMed ID: 19667675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin glargine: long-acting basal insulin analog for improved metabolic control.
    Gerich JE
    Curr Med Res Opin; 2004 Jan; 20(1):31-7. PubMed ID: 14741069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin analogues with improved absorption characteristics.
    Brange J; Hansen JF; Langkjaer L; Markussen J; Ribel U; Sørensen AR
    Horm Metab Res Suppl; 1992; 26():125-30. PubMed ID: 1490679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
    Dupre J
    Regul Pept; 2005 Jun; 128(2):149-57. PubMed ID: 15780434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in diabetes for the millennium: insulin treatment and glucose monitoring.
    Einhorn D
    MedGenMed; 2004 Sep; 6(3 Suppl):8. PubMed ID: 15647713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in insulin treatment of children.
    Steck AK; Klingensmith GJ; Fiallo-Scharer R
    Pediatr Diabetes; 2007 Oct; 8 Suppl 6():49-56. PubMed ID: 17727385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining effective insulin analog therapy based on the individualized needs of patients with type 2 diabetes mellitus.
    Gong WC
    Pharmacotherapy; 2008 Oct; 28(10):1299-308. PubMed ID: 18823224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the treatment of diabetes-insulin analogues.
    Vajo Z; Duckworth WC
    Minerva Endocrinol; 2002 Sep; 27(3):167-80. PubMed ID: 12091792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quest for physiologic insulin replacement.
    Owens DR
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):4-12. PubMed ID: 19667674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin detemir: a new basal insulin analogue.
    Soran H; Younis N
    Diabetes Obes Metab; 2006 Jan; 8(1):26-30. PubMed ID: 16367879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.